1H-Pyrazole-3-sulfonamide - CAS 1797158-84-9
Catalog: |
BB061830 |
Product Name: |
1H-Pyrazole-3-sulfonamide |
CAS: |
1797158-84-9 |
Synonyms: |
1H-pyrazole-3-sulfonamide; 1H-pyrazole-5-sulfonamide; pyrazole-sulfonamide; 5-(sulfonamido)pyrazole |
IUPAC Name: | 1H-pyrazole-5-sulfonamide |
Description: | 1H-Pyrazole-3-sulfonamide may be useful in the preparation of macrocycles as modulators of CFTR in the treatment of cystic fibrosis. |
Molecular Weight: | 147.15 |
Molecular Formula: | C3H5N3O2S |
Canonical SMILES: | C1=C(NN=C1)S(=O)(=O)N |
InChI: | InChI=1S/C3H5N3O2S/c4-9(7,8)3-1-2-5-6-3/h1-2H,(H,5,6)(H2,4,7,8) |
InChI Key: | LSJVQKDTVCDSPE-UHFFFAOYSA-N |
References: | Abela, A. R., et al. PCT Int. Appl., 983pp., WO 2021030556 (2021). |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113045498-A | 1, 5-diaryl pyrazole derivative, synthesis method and application | 20210324 |
CN-111423376-A | Isopimaric acyl heterocyclic sulfonamide derivative and preparation method and application thereof | 20200519 |
CN-111056978-A | Sulfonamide compound and preparation method and application thereof | 20191213 |
CN-111056978-B | Sulfonamide compound and preparation method and application thereof | 20191213 |
WO-2021030556-A1 | Modulators of cystic fibrosis transmembrane conductance regulator | 20190814 |
TW-202115094-A | Modulators of cystic fibrosis transmembrane conductance regulator | 20190814 |
WO-2020210139-A1 | Pyrazolesulfonamides as antitumor agents | 20190410 |
EP-3953331-A1 | Pyrazolesulfonamides as antitumor agents | 20190410 |
CN-109633065-B | Method for detecting drug residues in animal body | 20181228 |
WO-2020117493-A1 | Method for preparing n-phenylpyrazole-1-carboxamides | 20181203 |
PMID | Publication Date | Title | Journal |
21190552 | 20101229 | Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease | Alzheimer's research & therapy |
Complexity: | 182 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 147.01024758 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 147.01024758 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 97.2Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.9 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
-
[79407-66-2]
3-(2,4-Dihydroxyphenyl)-2-propenal
-
[1195209-18-7]
H-Glu-nh2 Hydrochloride
-
[635319-09-4]
(3R,4R)-tert-Butyl 3-Hydroxy-4-(hydroxymethyl)pyrrolidine-1-carboxylate
-
[1450663-24-7]
(3R,4R)-tert-Butyl 4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidine-1-carboxylate
-
(2R,5S,10aS,10bS)-10b-Hydroxy-5-isopropyl-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine-2-carboxylic Acid
-
[773057-66-2]
(4-Aminobenzyl)phosphonic Acid Hydrochloride
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS